Our team of analysts have screened the abstract contents in preparation for the presentations and posters release at AACR. So far, 98 abstract titles have been identified as relevant to trial or drug pages on Beacon ADC, including traditional antibody drug conjugates and non traditional drug conjugates. The majority of these abstracts are related to the preclinical stage of development.

Data from AACR 2022 will be populated on Beacon over the coming weeks. Remember that you can keep an eye on the trials and drugs that you’re most interested in by adding them to your personal watch list on Beacon. This will send you a notification when the page gets updated.

Find out more

 

This insight and data is part of the subscription to Beacon ADC.

Beacon ADC Logo

 

 Find out more 

Speak with our Team

Our dedicated team is on hand to showcase how Beacon can help you find the answers to your ADC questions.

Jake Morris Jia He

Request a Demo

About Beacon Targeted Therapies

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.

 

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

logo
Verified by MonsterInsights